Abviro LLC
Bethesda, MD
- UEI
- K3L6KXJ9B6M7
- CAGE
- 75YF3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4800 Hampden Ln #200, Bethesda, MD 20814, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| To conduct a phase 2 dengue human challenge clinical trial of abviro anti-dengue monoclonal antibody (MAB) AV-1. | National Institute of Allergy and Infectious Diseases | $11,335,102 | |
| - a broad-spectrum antibody therapeutic against flavivirus infections. | National Institute of Allergy and Infectious Diseases | $29,175,011 |
Quick answers
What is Abviro LLC's UEI?
Abviro LLC's Unique Entity ID (UEI) in SAM.gov is K3L6KXJ9B6M7.
What is Abviro LLC's CAGE code?
Abviro LLC's CAGE code is 75YF3.
What is Abviro LLC's primary NAICS code?
Abviro LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Abviro LLC located?
Abviro LLC's physical address in SAM.gov is 4800 Hampden Ln #200, Bethesda, MD 20814, USA.
Is Abviro LLC registered in SAM.gov?
Yes. Abviro LLC's SAM.gov registration is active through September 3, 2027.
What is Abviro LLC's most recent federal award?
Abviro LLC's most recent federal contract award is To conduct a phase 2 dengue human challenge clinical trial of abviro anti-dengue monoclonal antibody (MAB) AV-1 (75N93023C00055), from National Institute of Allergy and Infectious Diseases, on September 25, 2023.
On GovTribe
See Abviro LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors